CERN Cerner Corporation

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer

Experienced Clinical Executive to Lead Patient and Caregiver Experiences

KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality and patient safety, regulatory, health policy, government affairs and continuous improvement organizations.

Dr. Afsar is an experienced physician and healthcare executive with more than a decade of leadership responsibilities in large complex healthcare delivery systems, including UCLA Health and UCI Health. Previously, she has served as Chief Operating Officer, Chief Quality Officer and Associate Chief Medical Officer, delivering large scale and sustainable outcomes in quality, population health management, operations, finance, contracting, business development and strategy. She is the past president of Society of Hospital Medicine and has served on the Board of Directors for eight years. Dr. Afsar received her MD from UC Davis, School of Medicine and completed her Internal Medicine residency at UCLA Health. She received her MBA from UCLA Anderson School of Management.

“I am thrilled that Nasim is joining our team to help us realize the true promise of what the EHR can bring. Technology must work better for caregivers and patients,” said David Feinberg, MD, CEO and president, Cerner. “As an industry, we need to decrease the cost of care, improve quality and community health, give more time back to caregivers to spend at the bedside – and Cerner intends to be a key player in driving these efforts. I look forward to Nasim’s guidance and leadership.”

Throughout her career, Dr. Afsar has led forward-thinking and ambitious healthcare strategies across multiple organizations. She joins Cerner with extensive experience in bringing forth and implementing healthcare technologies that transform care delivery and focus on enhancing health and value to patients, communities and caregivers.

“I have dedicated my career to driving positive large-scale impact with the goal of delivering high quality care and health outcomes for our patients and communities. I am excited to continue this work at Cerner,” said Dr. Afsar. “We have not realized the full potential of healthcare technologies in supporting health, as well as providing early warning signs for chronic conditions and acute illnesses. I look forward to joining the talented team of leaders at Cerner to enhance our ability to care for patients and free our caregivers to focus on what matters most: the patient in front of them.”

About Cerner

health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit ,  or connect on , , ,  or . Nasdaq: CERN. Healthcare is too important to stay the same.



Media Contacts:

Cerner

Angela Vogen, Cerner Media Relations,  
EN
16/11/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cerner Corporation

CERNER sees an upgrade to Slightly Positive due to a better fundamenta...

The general evaluation of CERNER (US), a company active in the Software industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 14, 2021, the closing price was USD 77.26 and...

 PRESS RELEASE

Cerner Announces Increased Quarterly Dividend

Cerner Announces Increased Quarterly Dividend Dividend of $0.27 per issued and outstanding share reflects 23% increase KANSAS CITY, Mo., Dec. 10, 2021 (GLOBE NEWSWIRE) --  (NASDAQ: CERN), a global healthcare technology company, today announced that its board of directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share, up 23 percent from the prior quarterly dividend of $0.22. The cash dividend will be payable January 11, 2022, to shareholders of record as of the close of business December 27, 2021. Cerner intends to pay regular quarterly cash dividend...

 PRESS RELEASE

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Offic...

Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer Experienced Clinical Executive to Lead Patient and Caregiver Experiences KANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and caregivers. She will also lead the quality...

 PRESS RELEASE

Cerner Reports Third Quarter 2021 Results

Cerner Reports Third Quarter 2021 Results Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed as well as on the company’s website at . Cerner will host an earnings conference call to provide additional detail on the Company’s results a...

 PRESS RELEASE

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcome...

Cerner Enviza Aims To Accelerate Therapies And Improve Patient Outcomes Combining decades of healthcare, life sciences and collaborative research to transform the way care is delivered KANSAS CITY, Mo., Oct. 26, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: CERN), a global healthcare technology company, announces the launch of a new operating unit, SM, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate discovery, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch